Cardinal Health Inc.

The operator of a pharmacy chain has filed for Chapter 11 bankruptcy.

Here are the stocks making the biggest market moves today.

Total cash return consists of share buyback yield and dividend yield. The top stocks include two financial services companies.

McKesson is the S&P 500's second-best performing non-energy stock this year. Here's how the charts look now.

The S&P 500 High Dividend Index, which includes 80 stocks with high yields, has returned 3.6% to date.

'We rely on income from dividends to help when markets become volatile,' Ryan Fause of Pinnacle Associates told Reuters.

In partnership with Zipline, the retail giant just launched a pilot drone delivery program in Arkansas.

Cardinal Health, a major health-care-products distributor, hopes to counter delays and rising shipping costs by using drones.

Bank of America double-downgraded Cardinal Health after it issued a weaker-than-expected earnings forecast. The stock is lower.

Drug maker and distributors reach deal to settle more than 3,000 lawsuits over deadly opioid epidemic.

Johnson & Johnson, Cardinal Health, McKesson and AmerisourceBergen reportedly will pay up to $26 billion to settle opioid claims.

Cardinal Health reduces its full-year guidance after missing Wall Street's third-quarter estimates. The stock is lower.

Pharmaceutical distributor Cardinal Health plans to sell its medical device business to private-equity firm Hellman & Friedman for about $1 billion.

Stock futures rise ahead of the U.S. jobs report for January; Ford will invest $29 billion in EVs and driverless-car tech; Robinhood lifts limits on buying GameStop and AMC.

Cardinal Health topped earnings estimates even as it took a $1 billion charge related to opioid litigation.

You can buy your favorites on weakness under these circumstances.

Cardinal Health's earnings surged past analyst estimates for the first three months of 2020 as demand for drugs and medical products surged amid the coronavirus crisis.

Stock futures suggest a lower start for Wall Street; Under Armour reports earnings; Stage Stores files for bankruptcy.

The 21 U.S. state attorneys general who sued opioid makers rejected a settlement offer of $18 billion from three drugmakers that were looking to end the litigation against them, a media report says.

Should Google fear the reaper? And is the stock a buy here? Short-term, CPI will tell Wednesday's tale. It may or may not lean towards supporting short-term rate cuts. Long-term? Well...

After checking the charts and indicators, CAH investors should take note.

These recently downgraded names are displaying both quantitative and technical deterioration.

The 'Big 3' pharmaceutical distributors stand to benefit from the aging U.S. population and raise their payouts each year.

We're removing a name from the Bullpen as we wait for the right price to bring another stock into the portfolio.

Keep a close eye on this key technical level as the Nasdaq Composite keeps losing ground.

These blue chip names should 'age well' for income-oriented investors.

When it comes to finding a high-quality dividend stocks to own, the list of 'Aristocrats' is a great place to start.

Here's why investors should take a closer look at AbbVie, Cardinal Health and Walgreens Boots Alliance -- and their solid dividends.

These picks are attractive for value-oriented dividend investors looking for strong current income potential.

Plus, Thursday was a solid day for nearly all sectors of the market, though Peloton Interactive pulls back after posting results.

Top investment ideas from seven of CFRA Research's equity analysts.

We are interested in McKesson, one of the 'Big Three' pharmaceutical distributors in the U.S.

With 33 years of consecutive dividend increases, this health care name is a member of the Dividend Aristocrats Index.

CAH could rise more, but beware of betting the nest egg until the indicators confirm the gap up.

Pull in timelines and focus on stocks that will ultimately do well in a post-Covid world.

Collateral damage from the trade war is clearly causing ripple effects across global markets.

Cardinal Health's depressed stock price may be poised for a rebound.

Cardinal Health and McKesson have similar business models, but they are very different stocks.

The world-renowned hedge fund manager explains what could happen to the S&P 500 in 2025.

Credit card holders should keep an eye out for this update.

Doug McMillon is putting himself in front of a potential issue in 2025.